HomeBALAXI • NSE
add
Balaxi Pharmaceuticals Ltd
Previous close
₹17.27
Day range
₹17.47 - ₹18.55
Year range
₹17.05 - ₹73.70
Market cap
997.05M INR
Avg Volume
149.42K
P/E ratio
10.55
Dividend yield
-
Primary exchange
NSE
Market news
CABR
0.11%
2.45%
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 725.42M | -1.02% |
Operating expense | 282.77M | 9.00% |
Net income | 3.05M | -94.31% |
Net profit margin | 0.42 | -94.26% |
Earnings per share | — | — |
EBITDA | 29.57M | -25.85% |
Effective tax rate | 81.05% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 388.49M | -36.17% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 2.38B | — |
Shares outstanding | 50.83M | — |
Price to book | 0.38 | — |
Return on assets | — | — |
Return on capital | 2.15% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 3.05M | -94.31% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1942
Website
Employees
600